Professor of Medicine, UCLA
Hematology
Dr. Gary J. Schiller, MD
|
|
Give Review
Gary Schiller practices Hematology. He went to medical school at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31/72 in Research/PrimaryCare. He over the years received 5 awards: "America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California" and "Super Doctor". Gary J. Schiller is also a published physician. He has 42 publication published. The most recent publication is: Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, doubl... He accepts all Medicare patients.
Publications
- Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory Acute myeloid leukaemia (VALOR): a randomised, controlled, doubl...
- New Cancers after autotransplantations for multiple myeloma.
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor Acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
- Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.
- Emerging strategies for high-risk and relapsed/refractory Acute myeloid leukemia: Novel agents and approaches currently in clinical trials.
- Evolving treatment strategies in patients with high-risk Acute myeloid leukemia.
- Allogeneic Transplantation as Therapy for Acute Myelogenous Leukemia in the Elderly.
- Myelodysplasia.
- High-Dose Cytarabine (HD araC) in the Treatment of Leukemias: a Review.
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Treatment of adults with Acute lymphoblastic leukemia: Do the specifics of the regimen matter?: Results from a prospective randomized trial.
- High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
- Oral sapacitabine for the treatment of Acute myeloid leukaemia in elderly patients: a randomised phase 2 study.
- Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy.
- Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial.
- Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with Acute myelogenous leukemia in first remission.
- Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem Cell transplantation recipients.
- Prediction of dementia in primary care patients.
- When a gold standard is made of tin.
- Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with Acute myeloid leukem...
- Control of plasma uric acid in adults at risk for tumor Lysis Syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared wit...
- Hematopoietic stem-cell transplantation for Acute leukemia in relapse or primary induction failure.
- CMV central Nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency.
- Myelodysplastic Syndrome: An update on diagnosis and therapy.
- Outcome of transplantation for myelofibrosis.
- Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk Acute myeloid leukemia.
- Multicenter, phase II study of decitabine for the first-line treatment of older patients with Acute myeloid leukemia.
- Current status of Acute myeloid leukemia treatment in the elderly.
- Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or pri...
- Is the International Staging System superior to the Durie-Salmon staging System? A comparison in multiple myeloma patients undergoing autologous transplant.
- Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma.
- The graft-versus-Leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
- Comparison of twin and autologous transplants for multiple myeloma.
- Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
- Phase II multicenter study of arsenic trioxide in patients with myelodysplastic Syndromes.
- Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
- Clinical resistance to the kinase inhibitor PKC412 in Acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain.
- The evolution of antibodies into versatile tumor-targeting agents.
- Elimination of Aspergillus infection in allogeneic stem Cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment.
- Re: allogenic transplantation after nonmyelosuppressive conditioning--the effect of single-agent pentostatin.
- Treatment of Scedosporium apiospermum Brain abscesses with posaconazole.
Schools
University of Southern California Keck School of Medicine
University Of California Los Angeles
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Super Doctor
Education
-
UCLA Medical Center -
Keck School of Medicine of USC
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1851311930 | |
| NPPES Provider LastName | SCHILLER | |
| NPPES Provider FirstName | GARY | |
| NPPES Provider ZIPCode | 90095 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 676.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851311930 |
| Last Name Of The Provider | SCHILLER |
| First Name Of The Provider | GARY |
| View All |
Similar Doctors
|
|
Dr. Andy Y. Su, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle Afkhami, MD |
|
|
Dr. James H. Breeden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen B. Bredt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Katz, MD |
|
|
Dr. Leonid M. Kleynberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gino K. In, MD |
|
|
Dr. Kenneth M. Labowe, MD |
|
|
Dr. Joon S. Lee, MD |
|
|
Dr. Margaret K. Yu, MD |
|
|
Dr. Sarmad Sadeghi, MD
This Doctor is OpenDoctor Recommended.
|